Report: Unknown NBA player involved in Biogenesis scandal
By Royce Young | NBA writer
The NBA is hoping to have HGH testing in place for next season, according to CBSSports.com's Ken Berger.
But it might already be a problem.
The performance enhancing drug scandal linked to the Florida Biogenesis clinic that's wrapped up Major League Baseball with Ryan Braun being suspended for 65 games could include an NBA player.
When the Miami New Times broke the story months ago, it was on the back of Porter Fischer's information. And now he's told ESPN's Outside the Lines that NBA players are among many others that have used the clinic.
Fischer said he and associates have identified athletes from the NBA, NCAA, professional boxing, tennis and MMA, in addition to other professional baseball players who have not yet been identified. As far as he knows, Fischer said, Bosch had no clients from the NFL or NHL.
He said the only sports entity he has heard from was Major League Baseball.
The athletes not yet publicly named come from the documents Fischer took from the clinic, documents he said another employee asked him to take for safekeeping. The number of athletes involved with the clinic, based on what he saw and heard during his time with Biogenesis, is far more than people realize, he said.
Fischer has had a few inconsistencies in his information. But the documents are hard to dispute, especially with named players on them.
Again as Berger reported, the NBA is trying to implement an HGH policy. It already has a testing procedure for PEDs, though. A few players have been caught and suspended -- Rashard Lewis and Hedo Turkoglu most recently -- but the NBA has mostly avoided the perception of PEDs and HGH as a league-wide problem.
Via PBT
You May Also Like
Biggest Stories
" } //console.log(customStrings.signIn); callFBApi = function() { var accessToken; var uid; //CBSi.injectJS('//connect.facebook.net/en_US/all.js#xfbml=1', 'facebook-jssdk'); /* FB.init({ appId : '297742330311988', oauth : true }); */ FB.getLoginStatus(function(response) { if (response.status === 'connected') { handle_fb_response(response.authResponse); } else{ FB.login(function(response) { if (response.authResponse) { handle_fb_response(response.authResponse); /* uid = response.authResponse.userID; accessToken = response.authResponse.accessToken; //CBSi.log("== FB APP DATA ==", response); FB.api('/me', function(social) { //CBSi.log("== FB USER DATA ==", social); log_in_socially(social.name, social.username, 'fb'); document.cookie = "lf_social_info=|FB|; expires=0; path=/"; }); */ } }); } }); }; handle_fb_response = function(authResponse){ uid = authResponse.userID; accessToken = authResponse.accessToken; FB.api('/me', function(social) { //CBSi.log("== FB USER DATA ==", social); log_in_socially(social.name, social.username, 'fb'); document.cookie = "lf_social_info=|FB|; expires=0; path=/"; }); } log_in_socially = function(dn, userid, site) { $.ajax({ url: "/data/common/livefyre/lf_social_login", dataType: 'json', data: { lfdn: dn, lfuser: userid, ssite: site } }).done(function(profile) { //CBSi.log("== Social Login ==",profile,site); if (profile.error) { //CBSi.log("Social login failed with error: ", profile); return null; } else { document.cookie = "lf_social_login="+ profile.socialsess +"; expires=0; path=/"; profile.socialsess = '1'; userObj = profile; lf_user_profile = profile; doLivefyreAuth(profile); } }); }; callTwitterApi = function() { window.open('/common/livefyre/V3/via_twitter?debug=32','twitterOauth','width=600,height=500,menu=0,status=0'); }; callTwitterApiHidden = function() { var arr1 = readCookie('lf_social_info').split(/\|/); log_in_socially(arr1[2], arr1[3], 'twitter'); hasProfile = 1; } function doLivefyreAuth(cval) { //console.log("== Attempting LF Login ==",cval); var isLoggedIn = 1; if (cval) { try { fyre.conv.login(cval.token); } catch (e) { isLoggedIn = 0; } } } changeDOM = function() { // DOM hacks. Change the UI for the dropdown box //console.log("== Running Dom Hacks =="); if (isLoggedIn == 1){ //console.log("== Checking Match =="); if (hasProfile == 0) { //CBSi.log("== adding get comment link =="); // They need a screen name //$('.lf_auth_section a.lf_user_loggedout').html('Get a Screen Name to Comment').addClass('loginLink'); $('.fyre .fyre-user-loggedout').hide(); $('#getScreenName').show(); var screenNameContent = 'Get a Screen Name to Comment'; $('#getScreenName').html(screenNameContent); } /* else { if (typeof userObj.profile.profile_url != 'undefined'){ if (userObj.profile.profile_url) { //CBSi.log("== adding login profile links =="); $('.fyre .fyre-box-wrapper a.fyre-user-profile-link').attr('href',userObj.profile.profile_url); $('li.fyre-edit-profile-link').html('Edit Profile'); } } } */ } changedDom = 1; //console.log("== finished dom hacks =="); }; function updateCommentCounts(element,count){ //CBSi.log("== updating comment counts =="); if (count == 1){ $(element).html('' + count + ' ??| ?Comment'); $(element).show(); $('.commentsCountLabel').html('comment'); } else{ $(element).html('' + count + ' ??| ?Comments'); $(element).show(); $('.commentsCountLabel').html('comments'); } $('.commentsCount').html(count); } function removeLfError(){ $('#cbsLfError').remove(); } var authDelegate = new fyre.conv.RemoteAuthDelegate(); authDelegate.login = function (handlers){ if (isLoggedIn Please log in above to post a comment.
'); handlers.failure(); } else{ removeLfError(); handlers.success(); } }; function updateAuthorLinks(){ $('.fyre-comment-username').each(function() { $(this).click(function() { window.location.href = $(this).attr('href'); }); }); $('.fyre-comment-author').each(function() { $(this).click(function() { window.location.href = $(this).attr('href'); }); }); } function updateOneLineComments(){ //console.log("Checking Comments"); $(".fyre-comment-wrapper").each(function() { if ($(this).find(".fyre-comment").css('display') != 'none'){ var commentText = $(this).find(".fyre-comment").html(); if (commentText != null){ var loopCtr = 0; // for IE8 while ( (commentText.indexOf("
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.